The maker of blockbuster appetite-suppressing drugs Mounjaro and Zepbound is seeking to end a regulatory designation that has allowed cheaper, off-brand versions to flourish.
Source link : https://www.washingtonpost.com/business/2024/08/30/mounjaro-zepbound-eli-lilly-weight-loss-drugs/
Author : Daniel Gilbert
Publish date : 2024-08-30 19:41:52
Copyright for syndicated content belongs to the linked Source.
Trending
- Blue Monday : il s’habille tout en bleu, ses collègues préfèrent l’ignorer
- India court to sentence man in doctor rape, murder case
- BMW, Audi, Mercedes, Porsche… Pourquoi les ventes des grosses berlines allemandes calent
- Quién es Barron, el hijo menor de Donald Trump: cuánto mide, edad y su papel en la elecciones
- Mueren ocho personas en un incendio al parecer provocado en una residencia de ancianos en Serbia
- Quel est l’avenir de la guerre en Ukraine, maintenant que Donald Trump est de retour à la Maison-Blanche?
- UK set for ‘mega snow storm’ as maps pinpoint exact date and location it will hit
- The release of prisoners sparked scenes of joy in the West Bank – images Israel wanted to avoid
Monday, January 20